).
Therefore, the objectives of this study were to (1) investigate the relative frequency of preoperative versus intraoperative diagnosis of placenta accreta, (2) investigate the association between the diagnosis of placenta accreta at the time of cesarean hysterectomy and pathological diagnosis, and (3) test the hypothesis that compared with intraoperative diagnosis, preoperative diagnosis of placenta accreta is associated with a lower risk of intraoperative complications.
Materials and Methods
This is a retrospective cohort study of patients undergoing cesarean hysterectomy for suspected placenta accreta. All patients undergoing cesarean hysterectomy from 2000 to 2016 at Washington University School of Medicine in St. Louis for suspected placenta accreta were included. Placenta accreta was defined as placental invasion to (accreta), into (increta), or through (percreta) the myometrial wall. Patients were identified by searching the comprehensive billing database for relevant ICD-9 (International Statistical Classification of Diseases and Related Health Problems) and CPT (Current Procedural Terminology) codes capturing hysterectomy at the time of cesarean and placenta accreta. Patients were excluded if they underwent cesarean hysterectomy for other indications (e.g., uterine rupture, atony) or if placenta pathology reports were unavailable. The electronic medical records of all eligible patients were reviewed. We abstracted patient and pregnancy characteristics including preoperative diagnoses, imaging studies when available, intraoperative findings, and placental pathology results. The operative report (specifically the listed preoperative diagnosis, postoperative diagnosis, and operative findings) was used to determine the preoperative diagnosis as well as the intraoperative findings. In cases of ambiguity, the report was reviewed by multiple authors to achieve consensus.
We defined "clinical diagnosis" as any nonpathological diagnosis (made either preoperatively or intraoperatively), "preoperative diagnosis" as having placenta accreta listed as a preoperative diagnosis on the operative report or included in the indications for procedure, and "intraoperative diagnosis" as a clinical diagnosis first made at the time of cesarean section.
Patient and pregnancy information included maternal age, gestational age at delivery, race, height and weight at the time of delivery, obstetric history, number of prior cesarean deliveries, multiple pregnancies, tobacco use, and presence of placenta previa. Gestational age was based on the best obstetrical estimate as recorded in the medical record. All types of placenta previa (marginal, complete, etc.) were categorized as placenta previa. Imaging data included ultrasound and, in some cases, magnetic resonance imaging (MRI) reports. Pathological diagnoses were determined from the pathology report. In cases of multiple levels of invasion, the most severe was used (e.g., "placenta accreta with focal increta" was coded as "increta"). Surgical findings and complications were based on the operative report. The type of surgery was categorized as either cesarean total hysterectomy or cesarean supracervical hysterectomy. Intraoperative complications were categorized as cystotomy, ureteral injury, or other. Intentional cystotomies were recorded as "cystotomy." Admission to the intensive care unit was noted. Estimated blood loss was obtained from the operative report. Intraoperative blood transfusion of packed red blood cells was recorded in units based on the operative report and anesthesia record.
The primary outcome was the diagnosis of invasive placentation in the pathology report. Secondary outcomes were estimated blood loss and intraoperative complications. Test characteristics including positive predictive value and falsepositive rate with 95% confidence intervals (CIs) of clinical diagnosis were estimated with the pathology diagnosis of placenta accreta as the gold standard. Patients were categorized into two groups based on the timing of diagnosis of placenta accreta: preoperative or intraoperative, as discussed previously. Baseline characteristics and outcome measures were compared with the Mann-Whitney U-test or Fisher's exact test as appropriate.
Study data were collected and managed using REDCap electronic data capture tools hosted at the Washington University School of Medicine in St. Louis. 15 The study was approved by the Washington University in St. Louis Human Research Protection Office. Given that we included all women who met inclusion criteria and the sample size was fixed, we did not perform an a priori sample size calculation. Analyses were performed in SAS software (version 9.2, SAS Institute Inc., Cary, NC). A p-value of <0.05 was considered statistically significant. We did not adjust for multiple comparisons.
Results
From 2000 to 2016, 80 cesarean hysterectomies were performed: 52 of which were for suspected placenta accreta (2 had a missing pathology report, leaving a final sample size of 50) (►Fig. 1). The majority of these were in the years from 2013 to 2016 (n ¼ 28), with the remainder distributed relatively evenly over the preceding years. Of the 50 patients, 34 (68%) had a preoperative diagnosis of placenta accreta, whereas the diagnosis was first made intraoperatively in the remaining 16 (32%) at the time of cesarean delivery. The majority of patients (n ¼ 38; 76%) had a preoperative diagnosis of placenta previa and at least one prior cesarean delivery. Baseline characteristics were similar among patients diagnosed preoperatively and intraoperatively, with the notable exception that placenta previa and prior cesarean were more common among patients diagnosed preoperatively: placenta previa (97 vs. 44%; p < 0.0001) and mean number of prior cesareans (3 vs. 2; p ¼ 0.02) (►Table 1).
In all, 48 (96%) patients had confirmed placenta accreta in the pathology report, whereas 2 (4%) patients had no evidence of invasion. This corresponds to an overall positive predictive value of a clinical diagnosis of 96% (95% CI: 86.3%, 99.5%), and a false-positive rate of 4% (95% CI: 0.5%, 13.8%) (►Table 2).
Of the 16 patients with initial intraoperative diagnosis, 9 (56%) had an initial attempt to remove the placenta. The remainder did not have such an attempt due to visibly abnormal placentation at the time of the delivery. All patients who were first diagnosed intraoperatively (n ¼ 16) had pathological confirmation of placenta accreta. ►Table 3 shows the relationship between intraoperative diagnosis of the degree of abnormality and the pathological diagnosis. Of the two false-positive clinical diagnoses of placental invasion, one was thought to be a placenta accreta while the other was a suspected placenta increta. Both patients had a preoperative ultrasound diagnosis of placenta accreta.
Most patients (84%) had total cesarean hysterectomy, and the remainder (16%) had supracervical hysterectomy. There was no difference in total hysterectomy rates in patients with preoperative and postoperative diagnoses of placenta accreta (88 vs. 75%; p ¼ 0.25). The median blood loss was 2,500 mL for the entire cohort, with mean hospital length of stay of 4.5 days, with no differences between the groups diagnosed preoperatively versus intraoperatively. Nearly one in five women were admitted to the intensive care unit, with no differences in those diagnosed preoperatively and intraoperatively (21 vs. 13%; p ¼ 0.70) (►Table 4). There were no maternal deaths. Intraoperative surgical injury was common, with nearly one in three patients sustaining a cystostomy, ureteral injury, or other type of injury (n ¼ 16; 32%).
Discussion
We found that nearly one-third of diagnoses of placenta accreta were only made at the time of delivery. Additionally, although overall clinical diagnosis (preoperative and intraoperative) was largely accurate, there was a 4% falsepositive rate where the clinical diagnosis of placenta accreta was not confirmed on pathological examination. There were no significant differences in outcomes between patients diagnosed preoperatively and those diagnosed intraoperatively.
These findings indicate that when faced with a "surprise" potential placenta accreta, clinical diagnosis is highly accurate. The majority of the 16 patients with initial intraoperative diagnosis had an initial attempt to remove the placenta, suggesting that the diagnosis was indeed unexpected. Notably, all of these patients had pathological confirmation of placenta accreta, further suggesting that the abandonment of the placenta delivery attempt and the decision to perform hysterectomy was justified. The proportion of intraoperative versus preoperative diagnosis of placenta accreta in our study were similar to those in other studies, which have ranged from a preoperative diagnosis rate of 30 to 80%. 5, 6, 10, 14, 16 In a retrospective case series of 99 pathologically confirmed placenta accreta cases, 63% were diagnosed antepartum and the remaining 37% diagnosed at delivery. 14 On the other hand, in a recent study of 205 cases from the Nordic countries, 70% were undiagnosed preoperatively. 5 However, that study considered only clinical diagnosis and not pathological diagnosis. In our study, patients with risk factors were more likely to be diagnosed preoperatively, perhaps reflecting provider bias in more vigilantly searching for placenta accreta in patients with risk factors. Further study is needed to improve rates of preoperative diagnosis. 17 The diagnostic accuracy of ultrasound for abnormal placentation is variable, with a recent report citing a false-negative rate as high as 16%. 10 However, a meta-analysis noted that in experienced units, ultrasound is highly sensitive and specific for the diagnosis of placenta accreta with prenatal detection rates of >90%. 11 This variability in the accuracy of ultrasound diagnosis of abnormal placentation is likely because of the operator-dependent nature of ultrasound examinations. It is recognized that patients with placenta accreta have better outcomes when treated in a specialty center with multidisciplinary care.
7-9 However, it is unclear to what degree the patients managed by regular care in these studies had a suspected diagnosis prior to surgery. 8 Notably, a recent study from across the United States actually found worse outcomes in patients with a preoperative diagnosis compared with an initial intraoperative diagnosis, perhaps due to more severe disease. 4 The lack of significant differences in outcomes between patients with preoperative diagnosis and those with intraoperative diagnosis in our study may be attributable to the fact that patients were treated in a regional perinatal health care center with continuous access to advanced pelvic surgeons as well as robust intensive care and blood bank services. 18 Thus, outcomes may not be the same as in a community setting where an unplanned cesarean hysterectomy confers significantly more morbidity.
9
There were several strengths of our study. The study was conducted in an institution with common approaches to the diagnosis and management of placenta accreta. In addition, detailed data were abstracted, allowing for comprehensive analysis. However, there are limitations to be considered when interpreting our results. This is a retrospective cohort study based on chart review of patients identified through billing codes. While we used exhaustive codes to in an attempt to identify all patients meeting the inclusion criteria, there is a possibility that some patients were missed. Moreover, accuracy of the distinction between preoperative and intraoperative diagnosis of placenta was based on the listed diagnoses and descriptions in the operative reports, which may reflect provider bias. Although our sample size is comparable to prior studies, it is relatively small and may have impacted our ability to find statistically significant differences.
1,14,16 Finally, we did not have information about preoperative diagnoses of placenta accreta that were not clinically corroborated intraoperatively and therefore did not lead to cesarean hysterectomy. This made it impossible to estimate the test characteristics of preoperative imaging and diagnosis.
In conclusion, in our cohort, the diagnosis of placenta accreta was first made intraoperatively in nearly a third of cesarean hysterectomies. While most patients undergoing cesarean hysterectomy for clinically diagnosed placenta accreta had the diagnosis confirmed on pathological examination, there was a 4% false-positive rate. When faced with a clinical situation concerning for placenta accreta, clinicians can be reassured that clinical diagnosis is highly accurate. These findings reinforce the need for vigilance intraoperatively as the need for cesarean hysterectomy may not be anticipated preoperatively. As summarized in a recent editorial by Nageotte, clinicians must remain alert and ready for the potential for an undiagnosed placenta accreta at all times.
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